Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Endoplasmic reticulum-resident α-glucosidase II drives non-small cell lung cancer progression via regulation of secretory glycoproteins.
Journal: JCI insight
Published: December 05, 2025
EMT activates ER-to-Golgi trafficking through upregulation of REEP2 to promote lung cancer progression.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Osimertinib activates a TGF-β2-dependent secretory program that drives lung adenocarcinoma progression.
Journal: The Journal of clinical investigation
Published: July 25, 2025
Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression.
Journal: The Journal of clinical investigation
Published: November 12, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: September 21, 2024
The cancer-associated secretory phenotype: a new frontier in targeted therapeutics.
Journal: The Journal of clinical investigation
Published: September 03, 2024
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.
Journal: Cancer research
Published: May 15, 2024
A Lung Cancer Mouse Model Database.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
Hyaluronan network remodeling by ZEB1 and ITIH2 enhances the motility and invasiveness of cancer cells.
Journal: The Journal of clinical investigation
Published: March 06, 2024
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer.
Journal: The Journal of clinical investigation
Published: October 03, 2023
Last Updated: 09/26/2026